Sign In
Buy GRTS
$0.0322
+0 (+0%)
At Close: Nov 05, 2024
Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure
05:50am, Thursday, 10'th Oct 2024
EMERYVILLE, Calif.--(BUSINESS WIRE)--Gritstone bio, Inc. (Nasdaq: GRTS) (“Gritstone” or the “Company”), a clinical-stage biotechnology company working to develop the world's most potent vaccin
On Monday, Gritstone Bio Inc. GRTS revealed interim Phase 2 data from the ongoing Phase 2 study evaluating GRANITE, its individualized neoantigen-targeting immunotherapy, in frontline microsatellite-s
--Encouraging progression-free survival data in overall population; continued follow-up needed to allow data to mature further, especially in low ctDNA subgroup where events accrue more slowly
Investors Have The Opportunity To Lead The Gritstone bio, Inc. Securities Fraud Lawsuit With The Schall Law Firm
07:45pm, Thursday, 15'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gritstone bio, Inc. ("Gritstone
Gritstone bio Inc. (GRTS) Reports Q2 Loss, Misses Revenue Estimates
06:30pm, Tuesday, 13'th Aug 2024
Gritstone bio Inc. (GRTS) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.31 per share a year ago.
Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
04:05pm, Tuesday, 13'th Aug 2024
-- Preliminary randomized Phase 2 data suggest GRANITE (personalized neoantigen vaccine) could drive meaningful clinical benefit in front-line metastatic microsatellite-stable colorectal cancer (MSS-C
NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Gritstone bio, Inc. (NASDAQ: GRT
Investors Are Invited To Take The Lead In The Gritstone Bio Inc Securities Fraud Case With The Schall Law Firm
07:50pm, Wednesday, 07'th Aug 2024
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gritstone bio, Inc. ("Gritstone" or "the Company") (NASDAQ: GRTS ) for violation
Shareholders of Gritstone bio, Inc. Should Contact Levi & Korsinsky Before August 6, 2024 to Discuss Your Rights – GRTS
05:50pm, Tuesday, 06'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your Gritstone bio, Inc. (NASDAQ:GRTS) investment and want to learn about a potential recovery under the federal securities laws,
GRTS Investors Have The Opportunity To Lead Gritstone Bio Inc Securities Fraud Lawsuit With The Schall Law Firm
05:30pm, Tuesday, 06'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gritstone bio, Inc. ("Gritstone"
Levi & Korsinsky Notifies Gritstone bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - GRTS
03:45pm, Tuesday, 06'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your Gritstone bio, Inc. (NASDAQ:GRTS) investment and want to learn about a potential recovery under the federal securities laws,
GRTS LAWSUIT ALERT: Levi & Korsinsky Notifies Gritstone bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
10:15am, Tuesday, 06'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your Gritstone bio, Inc. (NASDAQ:GRTS) investment and want to learn about a potential recovery under the federal securities laws,
GRTS Investors Have the Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
10:00am, Tuesday, 06'th Aug 2024
LOS ANGELES , Aug. 6, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gritstone bio, Inc. ("Gritstone" or "
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your Gritstone bio, Inc. (NASDAQ:GRTS) investment and want to learn about a potential recovery under the federal securities laws,
Shareholders of Gritstone bio, Inc. Should Contact Levi & Korsinsky Before August 6, 2024 to Discuss Your Rights - GRTS
05:45am, Tuesday, 06'th Aug 2024
NEW YORK , Aug. 6, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Gritstone bio, Inc. ("Gritstone" or the "Company") (NASDAQ: GRTS) of a class action securities lawsuit. CLASS DEFIN
